Testing version — LOERadar is in active testing. Features and data may change.
ZOFRAN (ONDANSETRON HYDROCHLORIDE) | LOERadar
ZOFRAN
NDA
ONDANSETRON HYDROCHLORIDE | N020605 | SANDOZ INC
1 strength0 unique patents0 unique exclusivities
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
Para IV certification filed but no ANDA patent litigation cases (NOS 835) matched from PACER. Litigation may be pending or filed under a different caption.
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — EQ 4MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
RLD
0 patents0 exclusivities▴
SOLUTION;ORAL | Approved: Jan 24, 1997
No patent or exclusivity listings for this strength.